U.S. Marine and Shipping Stock News

Ionis Pharmaceuticals recently reported additional positive results from its pivotal Phase 1-3 trial of zilganersen in Alexander disease, showing statistically significant stabilization of gait speed and broad symptom benefits over 60 weeks, with the drug currently under FDA Priority Review and a PDUFA decision date set for September 22, 2026. Beyond motor endpoints, exploratory data showing reduced glial fibrillary acidic protein levels and consistently better patient- and...

AEVEX (NYSE:AVEX) has completed its public debut with an IPO that brought in fresh capital for the company. The company is using a portion of the new funds to acquire a stake in Athena Technology Solutions Holdings, expanding its presence in airborne intelligence. High profile mentions in financial media have increased attention on AEVEX's role in defense technology, particularly around drones and autonomous systems. AEVEX comes to market with NYSE:AVEX now trading around $35.99 and a year...

Why Zai Lab Stock Is Back on Investor Radar Zai Lab (NasdaqGM:ZLAB) has drawn fresh attention after a recent swing in performance, with the share price up over the past month and past 3 months, putting its biopharma pipeline back in focus for investors. See our latest analysis for Zai Lab. The recent 30 day share price return of 35.10% and 90 day share price return of 29.72% contrast with a 1 year total shareholder return of 24.87% and 5 year total shareholder return of 86.21%. This indicates...

Avnet stock performance snapshot Avnet (AVT) has drawn fresh attention after a strong run, with the share price at $75.26 and total returns of 28.76% over the past month and 47.83% over the past 3 months. See our latest analysis for Avnet. That recent 28.76% 1 month share price return and 47.83% 3 month share price return sit within a longer stretch of firm gains, with a 59.40% 1 year total shareholder return and 101.15% 3 year total shareholder return indicating sustained momentum. If you...

For investors considering whether Natera at around US$205 per share still offers value, or whether the recent run has already priced in the story, this article focuses on a straightforward question: what you are paying versus what you might be getting. The stock has been volatile recently, with a 4.3% decline over the past 7 days, a 5.2% gain over 30 days, and returns of a 10.2% decline year to date but 42.0% over 1 year and very large gains over 3 years. Recent news coverage has centered on...

Wondering whether HP's current share price reflects its true worth, or if the market is missing something important about this long established name in tech? HP's share price recently closed at US$21.09, with returns of 11.1% over 7 days and 15.4% over 30 days, while the 1 year return sits at an 8.4% decline and the 5 year return at a 26.7% decline. Recent coverage has focused on HP's position within the broader tech sector and how investors are reassessing established hardware and services...

For investors wondering whether Ulta Beauty at about US$570 a share is offering value or stretching expectations, this article walks through what the current price might imply for you as a shareholder. The stock has returned 7.0% over the last week, 7.6% over the last month, an 8.0% decline year to date, and 50.6% over the past year, which can influence how the market views both its potential and its risks. Recent attention on Ulta Beauty has focused on its role as a major U.S. beauty...

Sana Biotechnology and Mayo Clinic recently announced a collaboration to advance SC451, a hypoimmune-modified pancreatic islet cell therapy for type 1 diabetes, with Mayo contributing clinical expertise and making an initial US$25,000,000 equity investment plus an option for additional funding. The partnership aims to create standardized, scalable protocols for handling, delivering, and monitoring SC451 across diverse care settings, potentially strengthening both organizations’ roles in...

Over the last 7 days, the United States market has risen by 1.3% and is up 35% over the past year, with earnings expected to grow by 16% annually in the coming years. In this environment of robust growth, identifying stocks that are potentially undervalued can offer opportunities for investors seeking value amidst a rising market.

In April 2026, NASA selected Synopsys, Inc. and EMA to use advanced Ansys simulation tools and ground-based testing to verify Artemis lunar spacesuit compatibility with the Moon’s plasma and regolith environment, while also working with Cesium and NASA’s Glenn Research Center to model lunar communications coverage using Synopsys’ digital mission engineering platform. This collaboration highlights how Synopsys’ chip-to-systems simulation capabilities are being applied to high-stakes aerospace...

If you are wondering whether Himax Technologies at around US$11.64 still offers value, it helps to line up the recent share price performance against what the fundamentals suggest the business might be worth. The stock has posted returns of 16.6% over the past 7 days, 35.5% over 30 days, 36.5% year to date, 90.0% over 1 year, 107.4% over 3 years and 12.9% over 5 years, which naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused...

The United States market has experienced a robust performance, rising 1.3% over the last week and 35% over the past year, with earnings anticipated to grow by 16% annually. In this thriving environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business's operations and future prospects.

Over the last 7 days, the U.S. market has risen 1.3%, and over the past year, it is up by an impressive 35%, with earnings forecasted to grow annually by 16%. In light of these robust market conditions, identifying stocks with strong fundamentals becomes crucial for investors seeking stability and growth. While penny stocks might seem like a relic from past trends, they continue to offer intriguing opportunities in smaller or newer companies that demonstrate financial resilience and potential...

The United States market has shown robust performance, rising 1.3% over the last week and 35% over the past year, with earnings expected to grow by 16% annually. In such a dynamic environment, identifying small-cap stocks like Alto Ingredients that have strong growth potential and unique market positions can be key to uncovering hidden opportunities.

Wondering if EPR Properties at about US$56.56 is still offering value after its recent run, or if most of the easy gains are already behind it. The stock shows returns of 0.9% over 7 days, 12.1% over 30 days, 11.4% year to date, 22.1% over 1 year, 72.7% over 3 years, and 66.0% over 5 years, which provides useful context before weighing up what the current price might imply. Recent coverage around EPR Properties has focused on its role within the Specialized REITs space and investor interest...

What Firefly Aerospace’s recent performance means for stock watchers Firefly Aerospace (FLY) has drawn attention after a recent share move, with the stock up about 81% over the past month and roughly 46% over the past 3 months. This has prompted closer scrutiny from investors. See our latest analysis for Firefly Aerospace. The recent surge in Firefly Aerospace’s 30 day share price return of 81.3% and 90 day share price return of 45.6% sits alongside a year to date share price return of 77.2%...

The Federal Trade Commission has ordered Rollins (ROL) to stop enforcing noncompete agreements affecting more than 18,000 employees. This move raises fresh questions about labor flexibility, competition, and regulatory risk around the stock. See our latest analysis for Rollins. At a share price of US$54.71, Rollins has seen a 2.72% 1 month share price return but a 13.57% 3 month share price decline. Its 5 year total shareholder return of 62.31% contrasts with a slightly negative 1 year total...

Earlier this month, Douglas Emmett, Inc. acquired the Bedford Collection, a 246,000-square-foot, 95% leased outpatient medical portfolio in Beverly Hills’ Golden Triangle for US$260 million via a joint venture financed with a US$130 million, interest-only loan maturing in 2031 at SOFR plus 1.70%. This deal means Douglas Emmett now controls roughly one third of both the Golden Triangle’s medical office space and Beverly Hills’ Class A office inventory, concentrating high-value healthcare...

Jim Cramer highlighted Madison Air Solutions (NYSE:MAIR) shortly after its IPO, calling attention to the company on national financial media. Cramer pointed to Madison Air's rollup activity and acquisitions as key parts of its story. The stock most recently closed at $33.8, with a reported year to date return of 6.5%. For investors tracking newly listed names, NYSE:MAIR is now on the radar after its high profile IPO and Cramer endorsement. With a share price of $33.8 and a 6.5% return year...

Woodward’s pilot controls sale reshapes aerospace exposure Woodward (WWD) has agreed to sell its pilot controls product line and related services to Ontic Engineering and Manufacturing, including throttle quadrants, rudder pedals, and passive side sticks produced in Niles, Illinois. The deal includes customary closing conditions and regulatory approvals, as well as a long term supply agreement that keeps Woodward as the sole supplier of certain electromechanical components, and 9 to 12 months...

Shoals Technologies Group (SHLS) is back in focus after reporting 38.6% year on year revenue growth that topped expectations by 2.4%. The company paired upbeat next quarter guidance with full year EBITDA guidance that fell short. See our latest analysis for Shoals Technologies Group. The mixed earnings message appears to have cooled enthusiasm in the near term, with a 1 day share price return of a 3.0% decline and a 7 day share price return of a 4.9% decline. However, the 1 month share price...

Investors may be wondering whether W. R. Berkley at around US$65 a share still offers value, or if most of the opportunity has already been priced in. The stock has declined 0.9% over the past week and is down 5.7% year to date, following a 105.7% gain over the past 5 years. Recent coverage has focused on W. R. Berkley as a well known name in insurance, with investors watching how it positions itself against peers and broader sector trends. That backdrop helps explain why short term moves...

On April 10, 2026, CoreCivic, Inc. entered into a Second Amendment to its Fourth Amended and Restated Credit Agreement, adding a US$100 million incremental term loan to its US$800 million credit facility, largely to repay revolver borrowings and support working capital and general corporate needs. The prepayable, 364-day incremental term loan, priced 25 basis points above the company’s existing term and revolving debt, adjusts CoreCivic’s funding mix and short-term liquidity profile without...

Genesis Energy, L.P. previously declared quarterly cash distributions for the March 31, 2026 quarter, setting payments of US$0.18 per common unit and US$0.9473 per Class A Convertible Preferred unit, payable on May 15, 2026 to holders of record as of April 30, 2026. The announcement comes alongside revenue that exceeded analyst expectations, supported by strong offshore pipeline volumes and improved marine transportation utilization, underscoring the importance of its Gulf of Mexico...